Commentary
Searching for the Holy Grail of a staphylococcal vaccine
Downloads and Tools
Volume 6, Issue 12 December 2010
Pages 1068 - 1070
http://dx.doi.org/10.4161/hv.6.12.12917
Authors: Isaac Thomsen, Hannah Dudney and C. Buddy Creech
View affiliations Hide affiliations
- Isaac Thomsen
-
Department of Pediatrics, Division of Pediatric Infectious Diseases and the Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine and the Monroe Carell, Jr. Children’s Hospital at Vanderbilt
- Hannah Dudney
-
Department of Pediatrics, Division of Pediatric Infectious Diseases and the Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine and the Monroe Carell, Jr. Children’s Hospital at Vanderbilt
- C. Buddy Creech
-
Corresponding author: buddy.creech@vanderbilt.edu
Department of Pediatrics, Division of Pediatric Infectious Diseases and the Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine and the Monroe Carell, Jr. Children’s Hospital at Vanderbilt
Abstract:
The pursuit of an effective staphylococcal vaccine has never been more critical, as community-associated MRSA has become the most common bacterial infection in the US. In this commentary, we will highlight new discoveries in the host response to colonization and infection with S. aureus, discuss potential antigens that might be used as vaccines, and make recommendations as to how the field can move forward towards discovering the "holy grail" of an effective staphylococcal vaccine.
Preview: